PAAM Hybrid 2023

Back
02 - 04 November 2023 Porto, Portugal

Long-Term Dupilumab Treatment is Not Associated With an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis in an Open-Label Extension Study

Friday 03 Nov, 10:54 AM - 11:06 AM Porto/Portugal (CET -1)